Pharmacological inhibition of osteopontin with ALK5 inhibitor SM16 attenuated myocardial fibrosis in TAC mice but was associated with LV dilatation, systolic dysfunction, and increased mortality [128]. Here, SPP1 is linked to Myocardial fibrosis.